BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19096856)

  • 1. [Vasculitis. Treatment outcome parameters].
    Aries PM; Gause A
    Z Rheumatol; 2009 Feb; 68(1):44-8. PubMed ID: 19096856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rheumatoid arthritis. Target outcome for treatment].
    Aletaha D; Smolen J
    Z Rheumatol; 2009 Feb; 68(1):10-5. PubMed ID: 19148656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psoriatic arthritis. Treatment outcome parameters].
    Märker-Hermann E; Behrens F
    Z Rheumatol; 2009 Feb; 68(1):16-22. PubMed ID: 19148655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic sclerosis. Objectives for the treatment].
    Maurer B; Walder M; Gay RE; Gay S; Distler O
    Z Rheumatol; 2009 Feb; 68(1):37-43. PubMed ID: 19145444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systemic lupus erythematosus. Target criteria for treatment].
    Alexander T; Biesen R; Jacobi A; Hoyer B; Bruns A; Hiepe F
    Z Rheumatol; 2009 Feb; 68(1):23-9. PubMed ID: 19145446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9.
    Merkel PA; Herlyn K; Mahr AD; Neogi T; Seo P; Walsh M; Boers M; Luqmani R
    J Rheumatol; 2009 Oct; 36(10):2362-8. PubMed ID: 19820226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ankylosing spondylitis. Target treatment criteria].
    Braun J; Sieper J
    Z Rheumatol; 2009 Feb; 68(1):30-6. PubMed ID: 19145445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of vasculitides: according to recommendations of the European League Against Rheumatism (EULAR) and European Vasculitis Study Group (EUVAS)].
    Holle JU; Moosig F; Gross WL; ;
    Internist (Berl); 2011 Jun; 52(6):671-81. PubMed ID: 21512793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updating OMERACT Core Set of Domains for ANCA-associated Vasculitis: Patient Perspective Using the International Classification of Function, Disability, and Health.
    Milman N; McConville E; Robson JC; Boonen A; Tugwell P; Wells GA; Chaudhuri D; Dawson J; Tomasson G; Ashdown S; Gebhart D; Lanier G; Peck J; McAlear CA; Kellom KS; Cronholm PF; Merkel PA
    J Rheumatol; 2019 Oct; 46(10):1415-1420. PubMed ID: 30709951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vasculitis : EULAR/ACR guidelines with respect to the clinical cardiological routine].
    Maisch B
    Herz; 2015 Feb; 40(1):85-98. PubMed ID: 25676009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Childhood vasculitis].
    Kümmerle-Deschner JB; Thomas J; Benseler SM
    Z Rheumatol; 2015 Dec; 74(10):863-6, 868-72, 874-7. PubMed ID: 26597725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vasculitides].
    Hellmich B; Lamprecht P; Moosig F
    Z Rheumatol; 2015 Dec; 74(10):852-3. PubMed ID: 26597726
    [No Abstract]   [Full Text] [Related]  

  • 13. Recommendations of the Italian Society of Rheumatology for the treatment of the primary large-vessel vasculitis with biological agents.
    Pipitone N; Olivieri I; Salvarani C;
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S139-61. PubMed ID: 22640657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmet Needs in the Pathogenesis and Treatment of Vasculitides.
    Muratore F; Pazzola G; Soriano A; Pipitone N; Croci S; Bonacini M; Boiardi L; Salvarani C
    Clin Rev Allergy Immunol; 2018 Apr; 54(2):244-260. PubMed ID: 28895041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoimmune vasculitides. Standards and guidelines of EULAR and EUVAS].
    Moosig F; Holle JU; Gross WL;
    Internist (Berl); 2009 Mar; 50(3):298-309. PubMed ID: 19198789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small vessel vasculitis of the lung.
    Frankel SK; Cosgrove GP; Brown KK
    Chron Respir Dis; 2005; 2(2):75-84. PubMed ID: 16279155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [VASCULITIDES IN CHILDHOOD].
    Jelušić M; Frković M
    Reumatizam; 2016; 63 Suppl 1():80-5. PubMed ID: 29624307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
    Mukhtyar C; Hellmich B; Jayne D; Flossmann O; Luqmani R
    Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-93-8. PubMed ID: 17083770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EULAR recommendations for the management of primary small and medium vessel vasculitis.
    Mukhtyar C; Guillevin L; Cid MC; Dasgupta B; de Groot K; Gross W; Hauser T; Hellmich B; Jayne D; Kallenberg CG; Merkel PA; Raspe H; Salvarani C; Scott DG; Stegeman C; Watts R; Westman K; Witter J; Yazici H; Luqmani R;
    Ann Rheum Dis; 2009 Mar; 68(3):310-7. PubMed ID: 18413444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.